ArticlePharmaceuticals (Basel, Switzerland)2022

Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment.

Lu Turković et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.